Block Drug
Executive Summary
Acquires Glaxo's (ITALICS)Ethamolin(END ITALICS) (ethanolamine oleate). The orphan product, approved in December 1988 for the treatment of bleeding esophageal varices and launched by Glaxo last June, will be marketed by Block's Reed & Carnrick ethical drug division. There are some 33,000 potential Ethamolin patients, Block noted.